Cite
HARVARD Citation
Lu, G. et al. (2020). Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study. Lancet gastroenterology and hepatology. pp. 753-764. [Online].